Your browser doesn't support javascript.
loading
[Newest Reaserch Advance in treatment of Plasmablastic lymphoma--Review].
Liu, Dan; He, Xiao-Hui; Tao, Yun-Xia; Yang, Sheng.
Affiliation
  • Liu D; Department of Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • He XH; Department of Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China,E-mail:xiaohuih2008@163.com.
  • Tao YX; Department of Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Yang S; Department of Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi ; 28(4): 1410-1413, 2020 Aug.
Article in Zh | MEDLINE | ID: mdl-32798435

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Plasmablastic Lymphoma Limits: Humans Language: Zh Journal: Zhongguo Shi Yan Xue Ye Xue Za Zhi Journal subject: HEMATOLOGIA Year: 2020 Document type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Plasmablastic Lymphoma Limits: Humans Language: Zh Journal: Zhongguo Shi Yan Xue Ye Xue Za Zhi Journal subject: HEMATOLOGIA Year: 2020 Document type: Article Affiliation country: China